每經AI快訊，有投資者(zhe)在(zai)(zai)投資者(zhe)互動平臺(tai)提問：請問公司在(zai)(zai)生物制造領域有何強(qiang)項和優勢，未來(lai)的發展戰略(lve)是什(shen)么？

利(li)民股份（002734.SZ）1月(yue)3日在(zai)投資(zi)者互動平(ping)臺表(biao)示(shi)，公司將基(ji)(ji)于自(zi)身生(sheng)(sheng)(sheng)(sheng)物(wu)(wu)(wu)發(fa)酵(jiao)(jiao)及化(hua)(hua)學合成(cheng)(cheng)的(de)技術(shu)和資(zi)源(yuan)優(you)勢，緊跟政策(ce)導向和行業發(fa)展趨(qu)勢，重點(dian)布(bu)局(ju)“生(sheng)(sheng)(sheng)(sheng)物(wu)(wu)(wu)制造”產(chan)(chan)品(pin)(pin)方(fang)向，主(zhu)要包括(kuo)生(sheng)(sheng)(sheng)(sheng)物(wu)(wu)(wu)發(fa)酵(jiao)(jiao)工(gong)(gong)程產(chan)(chan)品(pin)(pin)、生(sheng)(sheng)(sheng)(sheng)物(wu)(wu)(wu)半合成(cheng)(cheng)產(chan)(chan)品(pin)(pin)、生(sheng)(sheng)(sheng)(sheng)物(wu)(wu)(wu)酶(mei)催(cui)化(hua)(hua)產(chan)(chan)品(pin)(pin)、基(ji)(ji)因(yin)工(gong)(gong)程等產(chan)(chan)品(pin)(pin)。運用(yong)合成(cheng)(cheng)生(sheng)(sheng)(sheng)(sheng)物(wu)(wu)(wu)學的(de)手段（菌(jun)種改造、代謝(xie)調控、分離純化(hua)(hua)、聚合工(gong)(gong)藝、應用(yong)開發(fa)）實(shi)現新產(chan)(chan)品(pin)(pin)產(chan)(chan)業化(hua)(hua)和傳統(tong)發(fa)酵(jiao)(jiao)工(gong)(gong)藝與酶(mei)法(fa)的(de)迭代升(sheng)級。 在(zai)生(sheng)(sheng)(sheng)(sheng)物(wu)(wu)(wu)發(fa)酵(jiao)(jiao)工(gong)(gong)程和生(sheng)(sheng)(sheng)(sheng)物(wu)(wu)(wu)半合成(cheng)(cheng)產(chan)(chan)品(pin)(pin)方(fang)面(mian)，以構建研發(fa)體(ti)系(xi)(xi)(xi)(xi)為基(ji)(ji)礎，形(xing)成(cheng)(cheng)阿維菌(jun)素(su)系(xi)(xi)(xi)(xi)列(lie)(lie)、多殺(sha)菌(jun)素(su)系(xi)(xi)(xi)(xi)列(lie)(lie)、側耳素(su)系(xi)(xi)(xi)(xi)列(lie)(lie)、米爾貝霉素(su)系(xi)(xi)(xi)(xi)列(lie)(lie)、泰樂(le)菌(jun)素(su)系(xi)(xi)(xi)(xi)列(lie)(lie)、全(quan)(quan)發(fa)酵(jiao)(jiao)法(fa)精(jing)(jing)草銨(an)膦(lin)等生(sheng)(sheng)(sheng)(sheng)物(wu)(wu)(wu)制造產(chan)(chan)品(pin)(pin)管線布(bu)局(ju)。 在(zai)生(sheng)(sheng)(sheng)(sheng)物(wu)(wu)(wu)酶(mei)催(cui)化(hua)(hua)產(chan)(chan)品(pin)(pin)方(fang)面(mian)，以生(sheng)(sheng)(sheng)(sheng)物(wu)(wu)(wu)酶(mei)催(cui)化(hua)(hua)法(fa)精(jing)(jing)草銨(an)膦(lin)技術(shu)成(cheng)(cheng)功合作為契(qi)機，戰略性(xing)開展生(sheng)(sheng)(sheng)(sheng)物(wu)(wu)(wu)酶(mei)催(cui)化(hua)(hua)系(xi)(xi)(xi)(xi)列(lie)(lie)產(chan)(chan)品(pin)(pin)研究，積極(ji)探索利(li)用(yong)生(sheng)(sheng)(sheng)(sheng)物(wu)(wu)(wu)酶(mei)催(cui)化(hua)(hua)代替傳統(tong)化(hua)(hua)學合成(cheng)(cheng)農獸藥。通過多種基(ji)(ji)因(yin)編輯技術(shu)（多基(ji)(ji)因(yin)調控技術(shu)、基(ji)(ji)因(yin)動態調控技術(shu)與蛋白骨(gu)架技術(shu)）提升(sheng)酶(mei)的(de)催(cui)化(hua)(hua)效(xiao)率，實(shi)現合成(cheng)(cheng)途徑的(de)優(you)化(hua)(hua)，提高(gao)產(chan)(chan)品(pin)(pin)的(de)生(sheng)(sheng)(sheng)(sheng)產(chan)(chan)速率。 通過踐(jian)行“精(jing)(jing)于生(sheng)(sheng)(sheng)(sheng)物(wu)(wu)(wu)科(ke)技 創造品(pin)(pin)質生(sheng)(sheng)(sheng)(sheng)活”的(de)使命(ming)，實(shi)現“成(cheng)(cheng)為全(quan)(quan)球領先的(de)植物(wu)(wu)(wu)保護和動物(wu)(wu)(wu)保健服務商”的(de)愿景。

(記者 王可然)

免責聲(sheng)明：本文內(nei)容(rong)與(yu)數(shu)據僅供參考(kao)，不構(gou)成(cheng)投資建議，使用(yong)前核實(shi)。據此操作，風險(xian)自擔(dan)。